DXR
DAXOR CORP
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$9.84
−2.09%Next report
Analyst consensus
- Next report date
- Mar 10, 2027
- EPS estimate
- —
- Revenue estimate
- $7.6K
Latest reported
- Last report date
- Aug 31, 2026
- EPS actual
- -$0.66
- EPS estimate
- -$0.06
- Revenue actual
- —
- Revenue estimate
- $2.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -780.7%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 31, 2026 | -$0.06 | -$0.66 | Miss -1000.00% | — |
| Jun 28, 2024 | — | -$0.34 | — | $71.8K |
| Aug 28, 2023 | — | -$0.32 | — | $81.0K |
| Mar 1, 2023 | — | $0.81 | — | — |
| Aug 25, 2022 | — | -$0.22 | — | — |
| May 15, 2022 | — | $0.78 | — | $152.4K |
| Nov 15, 2021 | — | -$0.19 | — | $125.7K |
| May 15, 2021 | $0.10 | $0.23 | Beat 128.40% | $145.5K |
| Nov 15, 2020 | $0.05 | -$0.85 | Miss -1795.08% | $118.9K |
| Feb 28, 2020 | -$0.04 | -$0.22 | Miss -456.30% | $187.2K |
| Nov 14, 2018 | — | -$0.17 | — | $229.5K |
| May 13, 2018 | — | -$0.17 | — | $275.3K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 10, 2027